Journal article
Clinical decision support improves quality of care in patients with ulcerative colitis
Belinda Jackson, Jake Begun, Kathleen Gray, Leonid Churilov, Danny Liew, Simon Knowles, Peter De Cruz
ALIMENTARY PHARMACOLOGY & THERAPEUTICS | WILEY | Published : 2019
DOI: 10.1111/apt.15209
Abstract
Background: Decision support tools may facilitate shared decision-making and improve quality of care. Aim: To assess the effectiveness of a decision support tool on improving quality of care in ulcerative colitis. Methods: A prospective quality of care intervention was conducted at two Australian hospitals comparing out-patient–based ulcerative colitis care with, and without, a tablet-based decision support tool. This included questions on disease activity management; psychological well-being; and preventive care, with 13 process indicators relevant to each domain. Participants included adult out-patients with mild-to-moderate ulcerative colitis and their clinicians who were divided into two..
View full abstractGrants
Funding Acknowledgements
This work was supported with the assistance of the Gutsy Group and an unrestricted educational grant support from Ferring. PDC has received educational grant support and been a speaker at educational symposia sponsored by Janssen, AbbVie, Takeda, Ferring, Shire and Baxter. PDC is on advisory boards for Janssen, Celgene, Takeda, Ferring, Shire and Baxter. BJ has received educational support from Ferring, Janssen and Takeda. SRK has received either educational grant support and/or been a speaker at educational symposia sponsored by Janssen, AbbVie and Shire. DL has received either grant support and/or been a speaker sponsored by AstraZeneca, Bristol-Myers Squibb, Novartis, Pfizer and Shire. JB has served as a speaker for Abbvie, Janssen, Takeda/Shire, Pfizer, Ferring, Gilead and Emerge Health. JB is on advisory boards for Anatara, Microba, Emerge Health, Ferring, Celgene, Takeda/Shire, Janssen and Abbvie. LC and KG have no personal interests to declare.